Changeflow GovPing Healthcare & Life Sciences Intraocular devices, systems, and methods
Routine Notice Added Final

Intraocular devices, systems, and methods

Favicon for changeflow.com USPTO Patent Grants - Prosthetics (A61F)
Published
Detected
Email

Summary

USPTO granted patent US12589025B2 to Sight Sciences, Inc. for intraocular implants configured to deliver drugs to the eye for treating eye conditions. The patent has 68 claims and names Paul Badawi, David Y. Badawi, and Daniel O'Keeffe as inventors. Filing date was May 27, 2022, with application number 17827573.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO granted Patent US12589025B2 to Sight Sciences, Inc. for intraocular implants designed to deliver drugs to eye structures including the posterior chamber (sulcus), iridocorneal angle, sclera, cornea, limbus, and vitreous. The patent contains 68 claims and was assigned CPC classifications A61F 9/0008, A61F 9/0017, and A61K 9/0051.

This is a routine patent grant notification with no compliance obligations or deadlines. Medical device manufacturers and pharmaceutical companies developing competing intraocular drug delivery systems should conduct freedom-to-operate analyses and consider potential licensing needs. The grant date is March 31, 2026.

Archived snapshot

Mar 31, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Intraocular devices, systems, and methods

Grant US12589025B2 Kind: B2 Mar 31, 2026

Assignee

SIGHT SCIENCES, INC.

Inventors

Paul Badawi, David Y. Badawi, Daniel O'Keeffe

Abstract

The present disclosure relates to intraocular implants for treating a condition of the eye, wherein the implant is configured to deliver a drug to the eye. The present disclosure also relates to methods of treating a condition of the eye by delivering a drug from intraocular implants to the posterior chamber (e.g., sulcus), iridocorneal angle, sclera, cornea, limbus, and vitreous.

CPC Classifications

A61F 9/0008 A61F 9/0017 A61K 9/0051

Filing Date

2022-05-27

Application No.

17827573

Claims

68

View original document →

Get daily alerts for USPTO Patent Grants - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12589025B2

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Grants - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!